FDA Approves Injectable Opdivo, Bristol Myers Squibb’s Blockbuster Cancer Drug
FDA approves injectable Opdivo, offering cancer patients a faster, more convenient alternative to IV infusions. This new formulation, Opdivo Qvantig, delivers the same powerful benefits in a subcutaneous injection.
FDA Approves Injectable Opdivo, Bristol Myers Squibb’s Blockbuster Cancer Drug Read More »